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Abstract—The aim of this experiment was to determine which 
cybersickness symptoms are associated with simulated motion, 
by comparing responses to the Simulated Sickness 
Questionnaire (SSQ) between a control and experimental 
condition. Using non-parametric statistical tests, we found that 
general discomfort, fatigue, headache, eyestrain, difficulty in 
focusing eyes, increased sweating, nausea, difficulty in 
concentrating, stomach awareness and blurred vision were 
significantly higher in a high simulated motion task compared 
with a low simulated task. The implications for preventing 
cybersickness in virtual environments are discussed. 
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I.  INTRODUCTION 
Virtual reality environments (VREs) provide innovative 
tools for research, professional training and recreational 
pursuits. VREs are expected to be widely deployed in 
coming years, as cost barriers to entry are reduced. However, 
in an era of legislated duty of care, and potential liabilities to 
employees, patients, students and consumers, VREs must be 
demonstrated to have safe operating limits. In particular, 
previous research on motion sickness symptoms arising in 
response to the use of virtual environments [1][2][3] has 
created health and safety concerns. Many of these symptoms 
are associated with perceived motion in a VRE, even when 
there is no physical motion of the subject who experiences 
these sensations. While there are competing theoretical 
explanations of why these cybersickness symptoms occur, 
our purpose in conducting research on these symptoms is to 
determine which symptoms can be attributed to being in a 
VRE versus being in a VRE with simulated motion. 
Unfortunately, a lot of research into cybersickness – even 
with quite sophisticated experimental designs – has lacked 
the rigor of a control condition to ensure that variance 
associated with simulated motion can be correctly attributed 
to a cause. 
Previous research has found that a twenty minute 
exposure to VREs can increase cybersickness symptoms in 
over 60% of participants [4]. Sharples [3]  investigated 
virtual reality induced symptoms and effects  and reported 
60 to 70%  of participants described increases in pre- and 
post-virtual reality exposure on a range of display 
conditions. The symptoms associated with computer-
generated environments are similar to those experienced 
when exposed to real movement, such as that felt when on a 
rocking boat, where there is visual and vestibular 
stimulation. In computer-generated VREs, there is no 
vestibular stimulation. The collective set of symptoms 
associated with the perception of motion when no physical 
motion exists is known as cybersickness [2] or Visually 
Induced Motion Sickness [1]. 
A standard questionnaire, the Simulator Sickness 
Questionnaire (SSQ) [5], has been developed to determine 
whether users of VREs experience cybersickness symptoms. 
Using the SSQ, previous studies have shown that exposure to 
simulated motion in a VRE produces mild to severe 
cybersickness symptoms in between approximately 50 to 
80% of participants [2]. Other studies have attempted to 
relate characteristic changes in the physiology of 
cybersickness with user responses on the SSQ, finding strong 
correlations between some self-report and physiological 
measures [2]. Since physiological measures are usually 
invasive and time-consuming, the results of Kim [2] indicate 
that the SSQ alone may be sufficient to determine whether a 
user is suffering cybersickness, since the SSQ uses a 
relatively straightforward scoring approach [5]. Quantifying 
simulator sickness symptoms should be a functional measure 
of the severity of the symptoms an individual  experiences 
and reports [5]. 
One weakness in both the Kim [2] and the Kennedy [5] 
studies is the absence of a baseline against which variance 
in responses on the 16 symptom variables of the SSQ can be 
attributed to simulated motion, as opposed to (say) just 
being inside a VRE. The identification of a baseline against 
which symptoms can be evaluated under different types of 
simulated motion is both valuable and necessary if (a) the 
self-report measures can properly be associated with 
simulated motion, and (b) useful for further understanding 
the theoretical underpinnings of simulated motion sickness, 
especially given the high correlation between physiological 
and self-report measures. 
A crucial feature of an experimental design is a control 
condition against which an experimental condition can be 
evaluated. We propose to measure changes in simulator 
sickness severity scores between a control and an 
2009 Sixth International Conference on Computer Graphics, Imaging and Visualization
978-0-7695-3789-4/09 $25.00 © 2009 IEEE
DOI 10.1109/CGIV.2009.83
486
experimental condition. While there are a number of 
potential control conditions, we have chosen to evaluate 
self-report responses between immersion in a VRE with low 
simulated motion compared to a high simulated motion 
condition. Thus, we assert that we can partition the variance 
due to being in a VRE alone, versus a VRE + simulated 
motion. Other psychological conditions – such as anxiety – 
have been shown to significantly increase when simulated 
motion increases [7]. 
In this study, we report the results of an experiment using 
the SSQ, to determine the effects of simulated motion on 
self-reports of cybersickness. Since all of the 16 measures in 
the SSQ have previously been associated with cybersickness, 
we predict that there will be significant increases in all 
cybersickness symptoms between the control and 
experimental conditions. 
II. METHOD 
A. Participants 
Twenty eight (10 female, 18 male) participants ranging in 
age from 18 – 30 years old participated in the experiment. 
All participants were student volunteers from Macquarie 
University.  All were healthy, as determined by a Health 
Questionnaire and had normal or corrected to normal vision. 
Participants were naïve to virtual immersive environments. 
Only participants who had no illnesses were accepted. 
Prior to the experiment a package was emailed to the 
student containing the Macquarie University Ethics 
Committee approved consent form, a health questionnaire 
and a comprehensive letter informing them not to eat or 
drink anything two hours prior to the experiment and not to 
consume illicit drugs or caffeine for 12 hours prior to the 
experiment.  
The consent form detailed the specific purpose of the 
experiment was to investigate motion sickness and explained 
their rights to discontinue the experiment at any time.  All 
participants were fluent in spoken and written English as 
determined by their enrolment in a degree program. No 
participant had been exposed to the virtual reality 
environment prior to the experimental session. The study 
complied with the Macquarie University Ethics Committee 
Approval. 
Written informed consent was obtained prior to the 
experiment.  
B. Experimental Protocol 
Participants were tested individually in a repeated 
measures design, where the participants acted as their own 
control. Prior experience remained constant over the entire 
experiment thereby maximizing sensitivity to the 
independent variable, since all participants were naïve to 
being exposed to the experimental virtual environments. 
Participants were seated in a chair placed centrally in front 
of the screen and instructed that they would be shown two 
six minute virtual reality environments and reminded that 
they could discontinue the experiment at any time during the 
course of the session. The experimenter verbally asked the 
participant “how are you feeling” during each condition of 
the experiment at 2 minutes and 4 minutes and participants 
orally answered.  
Prior to the experiment participants completed an 
Anxiety Scale [2]. The Simulator Sickness Questionnaire [5], 
Post Immersion Malaise Scale [5] and the Anxiety Scale [2] 
were administered after both the control and experimental 
conditions. 
C. Virtual Environments 
Two virtual reality immersive environments were 
shown to the participants. The control condition consisted of 
gentle flight over snow covered gently rolling hills (Fig. 1). 
The experimental condition involved a virtual rollercoaster 
ride that travelled along winding, ascending and descending 
tracks and through rickety tunnels (Fig. 2).  
Each immersive environment condition entailed a two 
minute continuous circuit which was played three times to 
give a six minute experience. The camera speed was 
constant at 20 metres per second in both the control and 
experimental conditions.  
The apparatus comprised of a curved front projection 
160° canvas screen (6.2m x 1.7m), three SEOS Cathode Ray 
Tube Projectors, Nuvision Stereo Shutter Goggles.  
 
 
 
Figure 1. Control condition – snow scene 
 
 
 
 
Figure 2. Experimental condition – rollercoaster 
Figure 2. Experimental condition – rollercoaster 
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III. RESULTS 
The results of the responses to the SSQ for post 
immersion in both the experimental and control conditions 
were analysed using the parametric matched samples t-test, 
and the non-parametric Wilcoxon Matched Pair Signed 
Rank Test. A non-parametric test was chosen since no 
assumptions were made about the normality of the 
distribution of the sample data, to confirm the results 
established by the parametric t-test. For all symptoms, there 
was complete agreement about the significance of results 
found. 
The results for the Matched  Samples t-test can be 
viewed in Table 1 and the Wilcoxon Matched Pair Signed 
Rank Test can be found in Table 2. Significant increases 
between the control and the experimental conditions were 
revealed for General Discomfort, Fatigue, Headache, 
Eyestrain, Difficulty in Focusing Eyes, Increased Sweating, 
Nausea, Difficulty in Concentrating, Stomach Awareness 
and Blurred Vision. No significant increases were observed 
for increased salivation, dizziness (eyes open or closed), 
vertigo, burping or fullness of head. 
TABLE I.  MATCHED SAMPLES T-TEST 
Symptom t-Test 
General Discomfort * t(27)=-3.31, p=0.003 
Fatigue * t(27)= -2.52, p=0.018 
Headache * t(27)= -2.27, p=0.031 
Eyestrain * t(27)= -3.95, p=0000 
Difficulty focusing eyes *  t(27)= -2.93, p=0.007 
Increased sweating * t(27)= -2.92, p=0.007 
Nausea * t(27)= -3.60, p=0.001 
Difficulty concentrating * t(27)= -2.35, p=0.026 
Stomach awareness * t(27)= -3.61, p=0.001 
Blurred vision * t(27)= -2.55, p=0.017 
Increased salivation t(27)=  0.36, p=0.720 
Dizziness Eyes Open t(27)= -1.61, p=0.118 
Dizziness Eyes Closed t(27)= -1.53, p=0.136 
Vertigo t(27)= -1.80, p=0.083 
Burping t(27)= -.891, p=0.381 
Fullness of head t(27)= -1.76, p=0.090 
* Significant value 
TABLE II.  WILCOXON MATCHED PAIR SIGNED RANK TEST 
Symptom Wilcoxon Test 
General Discomfort * z = -2.85, p=0.004 
Fatigue * z = -2.30, p=0.021 
Headache * z = -2.12, p=0.034 
Eyestrain * z = -3.20, p=0.001 
Difficulty focusing eyes *  z = -2.56, p=0.01 
Increased sweating * z = -2.54, p=0.011 
Nausea * z = -2.98, p=0.003 
Difficulty concentrating * z = -2.17, p=0.029 
Stomach awareness * z = -3.02, p=0.002 
Blurred vision * z = -2.33, p=0.02 
Increased salivation z = -1.09, p=0.272 
Dizziness Eyes Open z = -1.51, p=0.130 
Dizziness Eyes Closed z = -1.50, p=0.132 
Vertigo z = -1.73, p=0.084 
Burping z = -0.95, p=0.339 
Fullness of head z = -1.70, p=0.088 
*Significant value 
IV. DISCUSSION 
The results of this experiment indicate that self-report 
of 10/16 symptoms previously associated with 
cybersickness in a VRE significantly increase when 
simulated motion is increased, while 6/16 do not 
significantly increase. Since previous uncontrolled studies 
[2][5] had indicated that all 16 symptoms were associated 
with cybersickness, these results significantly enhance our 
aspect of perceived motion (eyestrain, difficulty focusing 
eyes, blurred vision), perceived nausea (nausea, stomach 
awareness, discomfort, fatigue) and cognitive (headache, 
difficulty concentrating). However, symptoms associated 
with gastric activity (salivation, burping) and vestibular 
activation (vertigo, dizziness) were absent. These results 
indicate that vection [8] rather than vestibular activation 
might be mediated through a cognitive route to generate the 
nausea symptoms. These results also accord with sensory 
conflict theory, since no actual vestibular activation is 
reported, and yet participants still feel nauseous [9].  
Further research is required to determine the exact 
relationships between these groups of variables, and/or their 
internal (factor) structure. Ultimately, a computational that 
predicts the levels of nausea symptoms given a set of input 
conditions (cognitive, perceptual) should be developed to 
better understand the dynamics of cybersickness arising 
from simulated motion. 
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